Methodological quality of COVID-19 clinical research.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 02 2021
Historique:
received: 16 07 2020
accepted: 13 01 2021
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 18 2 2021
Statut: epublish

Résumé

The COVID-19 pandemic began in early 2020 with major health consequences. While a need to disseminate information to the medical community and general public was paramount, concerns have been raised regarding the scientific rigor in published reports. We performed a systematic review to evaluate the methodological quality of currently available COVID-19 studies compared to historical controls. A total of 9895 titles and abstracts were screened and 686 COVID-19 articles were included in the final analysis. Comparative analysis of COVID-19 to historical articles reveals a shorter time to acceptance (13.0[IQR, 5.0-25.0] days vs. 110.0[IQR, 71.0-156.0] days in COVID-19 and control articles, respectively; p < 0.0001). Furthermore, methodological quality scores are lower in COVID-19 articles across all study designs. COVID-19 clinical studies have a shorter time to publication and have lower methodological quality scores than control studies in the same journal. These studies should be revisited with the emergence of stronger evidence.

Identifiants

pubmed: 33574258
doi: 10.1038/s41467-021-21220-5
pii: 10.1038/s41467-021-21220-5
pmc: PMC7878793
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

943

Subventions

Organisme : CIHR
Pays : Canada

Références

N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Lancet. 2014 Jan 18;383(9913):267-76
pubmed: 24411647
Ann Intern Med. 2020 Aug 18;173(4):287-296
pubmed: 32459529
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
Science. 2020 Jun 5;368(6495):1041-1042
pubmed: 32499418
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
Lancet. 2014 Jan 11;383(9912):176-85
pubmed: 24411646
BMJ. 2020 Jun 2;369:m2197
pubmed: 32487664
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
J Clin Epidemiol. 2020 Jul;123:120-126
pubmed: 32330521
JAMA Cardiol. 2020 Sep 1;5(9):1036-1041
pubmed: 32936252
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
J Eval Clin Pract. 2019 Feb;25(1):44-52
pubmed: 29484779
Lancet. 2014 Jan 11;383(9912):156-65
pubmed: 24411644
Travel Med Infect Dis. 2020 Mar - Apr;34:101663
pubmed: 32289548
N Engl J Med. 2020 Aug 6;383(6):517-525
pubmed: 32492293
BMJ. 2017 Jun 20;357:j2973
pubmed: 28634227
Int J Epidemiol. 2007 Jun;36(3):666-76
pubmed: 17470488
Lancet. 2014 Jan 18;383(9913):257-66
pubmed: 24411650
Lancet Rheumatol. 2020 Aug;2(8):e474-e484
pubmed: 32835257
Clin Med Res. 2009 Dec;7(4):147-56
pubmed: 19889943
Circ Res. 2017 Jun 9;120(12):1916-1926
pubmed: 28373349
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
Plast Reconstr Surg. 2011 Jul;128(1):305-310
pubmed: 21701348
J Clin Epidemiol. 1994 Sep;47(9):971-5
pubmed: 7730913
JAMA Netw Open. 2020 Apr 24;3(4):e208857
pubmed: 32330277
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
JAMA. 2017 Sep 26;318(12):1109-1110
pubmed: 28973598
Lancet. 2020 May 22;:
pubmed: 32450107
N Engl J Med. 2020 Jun 25;382(26):2582
pubmed: 32501665
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
Nature. 2020 Mar;579(7798):193
pubmed: 32157233
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168

Auteurs

Richard G Jung (RG)

CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Pietro Di Santo (P)

CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Cole Clifford (C)

Faculty of Medicine, University of Ottawa, Ontario, Canada.

Graeme Prosperi-Porta (G)

Department of Medicine, Cumming School of Medicine, Calgary, Alberta, Canada.

Stephanie Skanes (S)

Faculty of Medicine, University of Ottawa, Ontario, Canada.

Annie Hung (A)

Division of Internal Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

Simon Parlow (S)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Sarah Visintini (S)

Berkman Library, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

F Daniel Ramirez (FD)

CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, Bordeaux-Pessac, France.
L'Institut de Rythmologie et Modélisation Cardiaque (LIRYC), University of Bordeaux, Bordeaux, France.

Trevor Simard (T)

CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Benjamin Hibbert (B)

Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. bhibbert@ottawaheart.ca.
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. bhibbert@ottawaheart.ca.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. bhibbert@ottawaheart.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH